ReadiGraft® Demineralized Chips and Particulate

Download the files in the language of your choice
Instructions for Use
Product Specifications

ReadiGRAFT®

ReadiGraft® Demineralized Chips and Particulate

Demineralized bone chips and particulate designed to promote bone healing in patients with a high risk of non-union.

  • Osteoinductive Potential: Demineralized using proprietary PAD® technology that targets optimal residual calcium levels of 1-4% without compromising the grafts inherent osteoconductive properties or osteoinductive potential.1, 2
  •  Osteoconductive: Natural bone matrix facilitates cell attachment, cell proliferation, and vascular in‐growth.
  •  Sterile: Sterilized using proprietary and patented Allowash XG® technology which provides a sterility assurance level of 10-6 , without compromising the graft’s inherent osteoconductive properties.3
  •  Versatile: Available in multiple sizes and volumes to meet surgical needs.
  • Absorbent: Absorbs and retains bioactive fluids like blood, platelet rich plasma (PRP), and bone marrow aspirate (BMA).
Clinical Application

Any surgical application that requires bone void filler

Freeze-Dried Description Sizing
DCAN40 ReadiGraft Demineralized Cancellous Chips, 1 - 8 mm 40 cc
DCC1/4 ReadiGraft Demineralized Cortical/Cancellous Chips, 1 - 8 mm 20 cc
DGC20 ReadiGraft Demineralized Cortical Particulate, 125-1000 microns 20 cc
DGC40 ReadiGraft Demineralized Cortical Particulate, 125-1000 microns 30 cc
References
  1.  Zhang M, Powers R, Wolfinbarger L. (1997). Effect(s) of demineralization process on the osteoinductivity of demineralized bone matrix. J Periodontol, 68:1085-1092.
  2.  Turonis JW, McPherson JC 3rd, Cuening MF. (2006). The affects of residual calcium in decalcified freeze-dried bone allograft in a critical-sized defect in the Rattus norvegicus calvarium. J Oral Implantol. 32(2), 55-62.
  3.  Balsly CR, Cotter AT, Williams LA, Gaskins BD, Moore MA, Wolfinbarger L Jr. Effect of low dose and moderate dose gamma irradiation on the mechanical properties of bone and soft tissue allografts. Cell Tissue Bank. 2008;9(4):289-298. doi:10.1007/s10561-008-9069-0.